Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma.
暂无分享，去创建一个
M. Amiot | R. Vij | B. Pégourié | Shaji K. Kumar | P. Moreau | J. Leverson | J. Kaufman | C. Touzeau | J. Ross | T. Facon | E. Punnoose | S. Enschede | P. Maciag | M. Verdugo | S. Agarwal | M. Dunbar | L. Benboubker | J. Mikhael | C. Gasparetto | Tu Xu | Stefanie Alzate | T. Xu